Analytical evaluation of the diazyme glycated serum protein assay on the siemens ADVIA 1800: Comparison of results against HbA1c for diagnosis and management of diabetes

Journal of Diabetes Science and Technology

Volumn 9, Issue 2, 2015, Pages 192-199

  Rodriguez Capote, Karina ^a,b   Tovell, Kayla ^a   Holmes, Deborah ^a   Dayton, Janice ^a   Higgins, Trefor N ^a,b  

^a DynaLIFE Dx   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Diabetes mellitus; Glycated albumin; Glycated hemoglobin; Glycated protein; Glycemic markers; Hemoglobin A1c

Indexed keywords

GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; GLYCOSYLATED SERUM ALBUMIN; SERUM ALBUMIN;

ACCURACY; ANALYTIC METHOD; ANALYZER; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; HUMAN; LABORATORY AUTOMATION; PROTEIN DETERMINATION; SENSITIVITY ANALYSIS; VALIDATION STUDY; ADOLESCENT; ADULT; AGED; ANALYSIS; BLOOD; BLOOD ANALYSIS; COMPARATIVE STUDY; DEVICES; FEMALE; GLUCOSE BLOOD LEVEL; MALE; MIDDLE AGED; PROCEDURES; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD CHEMICAL ANALYSIS; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN; YOUNG ADULT;

EID: 84946724966     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296814567894     Document Type: Conference Paper

References (22)

1. Whaley-Connell A, Sowers JR. Implications for glucose measures in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes. 2014;63:45-47.
2. Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem. 2001;47:153-163.
3. Little RR, Rohlfing CL, Tennill AL, et al. Measurement of HBA(1c) in patients with chronic renal failure. Clin Chim Acta. 2013;418:73-76.
4. Koga M, Hashimoto K, Murai J, et al. Usefulness of glycated albumin as an indicator of glycemic control status in patients with hemolytic anemia. Clin Chim Acta. 2011;412:253-257.
5. Little RR, Rohlfing CL, Hanson S, et al. Effects of hemoglobin (hb) e and hbd traits on measurements of glycated hb (HbA1c) by 23 methods. Clin Chem. 2008;54:1277-1282.
6. Little RR, Roberts WL. A review of variant hemoglobins interfering with hemoglobin a1c measurement. J Diabetes Sci Technol. 2009;3:446-451.
7. Arasteh A, Farahi S, Habibi-Rezaei M, Moosavi-Movahedi AA. Glycated albumin: an overview of the in vitro models of an in vivo potential disease marker. J Diabetes Metab Disord. 2014;13:49.
8. Koga M. Glycated albumin; clinical usefulness. Clin Chim Acta. 2014;433:96-104.
9. Nathan DM, McGee P, Steffes MW, Lachin JM. Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study. Diabetes. 2014;63:282-290.
10. Nathan DM, Steffes MW, Sun W, Rynders GP, Lachin JM. Determining stability of stored samples retrospectively: the validation of glycated albumin. Clin Chem. 2011;57:286-290.
11. Abidin D, Liu L, Dou C, Datta A, Yuan C. An improved enzymatic assay for glycated serum protein. Analytical Methods. 2013;5:9.
12. CLSI. User Verification of Performance for Precision and Trueness; Approved Guideline. CLSI document ep15-A2. 2nd ed. Wayne, PA: CLSI; 2005.
13. CLSI. Protocols for Determination of Limits of Detection and Limits of Quantitation, Approved Guideline. CLSI document ep17-A. Wayne, PA: CLSI; 2004.
14. CLSI. Interference Testing in Clinical Chemistry; Approved Guideline. CLSI document ep7-A2. 2nd ed. Wayne, PA: CLSI; 2005.
15. CLSI. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline. CLSI document ep28-A3c. 3rd ed. Wayne, PA: CLSI; 2008.
16. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(suppl 1):S62-S69.
17. Furusyo N, Koga T, Ai M, et al. Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS). Diabetologia. 2011;54:3028-3036.
18. Higgins T, Saw S, Sikaris K, et al. Seasonal variation in hemoglobin A1c: Is it the same in both hemispheres? J Diabetes Sci Technol. 2009;3:668-671.
19. Furusyo N, Hayashi J. Glycated albumin and diabetes mellitus. Biochimica et Biophysica Acta. 2013;1830:5509-5514.
20. Bando Y, Kanehara H, Toya D, Tanaka N, Kasayama S, Koga M. Association of serum glycated albumin to haemoglobin A1c ratio with hepatic function tests in patients with chronic liver disease. Ann Clin Biochem. 2009;46:368-372.
21. Freedman BI, Shihabi ZK, Andries L, et al. Relationship between assays of glycemia in diabetic subjects with advanced chronic kidney disease. Am J Nephrol. 2010;31:375-379.
22. Koga M, Murai J, Saito H, Matsumoto S, Kasayama S. Effects of thyroid hormone on serum glycated albumin levels: study on non-diabetic subjects. Diabetes Res Clin Pract. 2009;84: 163-167.